title: The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis.
authors: Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences - University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy giovannibattista.migliori@fsm.it.
authors: Giovanni
authors: 0000-0002-1600-4474
authors: G
authors: Sotgiu
authors: University of California, San Francisco, CA, USA.
authors: Payam
authors: P
authors: Nahid
authors: German Central Committee against Tuberculosis (DZK), Berlin, Germany.
authors: Robert
authors: R
authors: Loddenkemper
authors: Institute for Global Health, University College London, London, UK.
authors: Ibrahim
authors: I
authors: Abubakar
authors: Pneumology Dept, Hospital Universitari Vall d'Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
authors: Marc
authors: M
authors: Miravitlles
authors: World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
authors: Giovanni Battista
authors: 0000-0002-2597-574X
authors: GB
authors: Migliori
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D019090:Case Management; D002487:Centers for Disease Control and Prevention, U.S.; D060085:Coinfection; D023801:Directly Observed Therapy / Q000379:methods*; D005060:Europe; D015658:HIV Infections / Q000150:complications; D006801:Humans; D010495:Pericarditis, Tuberculous / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D015272:Pulmonary Medicine; D012955:Societies, Medical; D014376:Tuberculosis / Q000150:complications / Q000000981:diagnostic imaging*; D014390:Tuberculosis, Meningeal / Q000188:drug therapy; D014481:United States
chemical_list: D000995:Antitubercular Agents